Accenture
ACN
$138.52
+2.43%
Accenture is a global leader in IT services and consulting, providing strategy, consulting, digital, technology, and operations services to enterprises worldwide. As the world's largest professional services firm by headcount with approximately 779,000 employees across 120+ countries, it holds a dominant market position in the information technology services industry. The stock has been under intense pressure in 2026, plunging over 50% year-to-date due to a weaker-than-expected fiscal 2026 revenue forecast, federal contract losses, and growing fears that AI automation could disrupt its traditional consulting and outsourcing business model. Despite these headwinds, the company continues to report record bookings and strong cash flow, creating a sharp debate between value-oriented investors and those concerned about structural disruption.…
ACN
Accenture
$138.52
Related headlines
Investment Opinion: Should I buy ACN Today?
Rating: Hold. Accenture is a high-quality business facing structural headwinds, and the current valuation is attractive but not yet compelling enough to buy given the severe downtrend and AI disruption risk. The analyst consensus leans bullish with an average target implying ~29% upside, but the stock's 53% decline reflects deep uncertainty.
Supporting Evidence: The forward P/E of 9.2x is near historical lows and well below the trailing P/E of 21.2x, suggesting value if earnings recover. Revenue is estimated at $97.6 billion, implying modest growth, but the net margin of 11.0% and operating margin of 14.7% remain healthy. Free cash flow is strong with a PCF ratio of 14.2x, and the balance sheet is solid with a debt-to-equity of 0.26. The implied upside to analyst targets is approximately 29% based on the forward P/E of 9.2x and EPS estimate of $18.92.
Risks & Conditions: The biggest risks are further revenue deceleration, AI disruption, and federal contract losses. This Hold would upgrade to Buy if the stock breaks below $118 with no further fundamental deterioration, or if forward guidance shows a clear inflection in consulting demand. It would downgrade to Sell if revenue growth turns negative or margins compress below 10%. Currently, the stock appears undervalued on a forward basis but overvalued on a trailing basis, reflecting high uncertainty.
Sign up to view all
ACN 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The stock's valuation is compelling on a forward basis, but the severe downtrend and structural AI threat create significant downside risk. The key factor to watch is whether the forward earnings recovery materializes or if the AI disruption proves more damaging. An upgrade to bullish would require evidence of a growth inflection, while a downgrade to bearish would follow further estimate cuts or a break below $118.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Accenture's 12-month outlook, with a consensus price target around $180.08 and implied upside of +30.0% versus the current price.
Average Target
$180.08
17 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
17
covering this stock
Price Range
$111 - $180
Analyst target range
Accenture is covered by 17 analysts, with a consensus recommendation leaning bullish (though specific buy/hold/sell distribution is not provided). The average target price is not explicitly given, but the estimated EPS average of $18.92 for the current fiscal year implies a forward P/E of 7.1x at the current price of $135.23, suggesting significant upside if that EPS is achieved. However, the lack of a stated average target price limits precision; based on the forward P/E of 9.2x from valuation data, the implied target would be around $174 (9.2 * 18.92), representing approximately 29% upside from current levels. The estimated EPS range is $18.69 to $19.29, and revenue estimates range from $96.7 billion to $99.1 billion, indicating relatively tight consensus on near-term fundamentals. The wide spread between trailing and forward P/E (21.2x vs 9.2x) suggests high uncertainty about earnings recovery, and the stock's 50% year-to-date decline reflects a loss of confidence. If analyst data were more complete, the low target would likely price in further margin compression and revenue decline, while the high target would assume a swift rebound in consulting demand. The recent downgrades and negative revisions (implied by the weak outlook) signal that analysts are turning more cautious, but the forward estimates still imply a sharp earnings recovery that may be overly optimistic given the structural AI threat.
Drowning in data?
Find the real signal!
Bulls vs Bears: ACN Investment Factors
Accenture presents a classic value trap versus deep value debate. The bull case rests on a rock-solid balance sheet, record bookings, strong cash flow, and a forward P/E of 9.2x that implies significant upside if earnings recover. The bear case is driven by a 53% stock decline, weak revenue guidance, AI disruption fears, and federal contract losses. Currently, the bearish evidence is stronger given the accelerating downtrend and structural threats, but the valuation is compelling enough to attract value investors. The single most important tension is whether the forward earnings recovery priced into the 9.2x P/E is realistic or overly optimistic given the AI disruption risk.
Bullish
- Record bookings and strong cash flow: Despite the 50% stock decline, Accenture reported record bookings and generated strong free cash flow, with a PCF ratio of 14.2x and EV/EBITDA of 12.3x. This indicates underlying business resilience and the ability to fund operations and dividends without external financing.
- Forward P/E of 9.2x implies deep value: The forward P/E of 9.2x is near historical lows and represents a significant discount to the trailing P/E of 21.2x, suggesting the market expects a sharp earnings recovery. If analyst EPS estimates of $18.92 materialize, the stock offers substantial upside from current levels.
- Healthy balance sheet with low debt: Accenture's debt-to-equity ratio is only 0.26, and the current ratio of 1.42 indicates adequate liquidity. This financial strength provides a cushion against the current downturn and allows the company to invest in growth initiatives like AI.
- AI adoption as a strategic catalyst: Accenture is aggressively embracing AI, making AI usage a requirement for senior promotions and acquiring firms like Verum Partners to enhance AI capabilities. This positions the company to capitalize on the AI transformation wave rather than be disrupted by it.
Bearish
- 53% stock decline and severe downtrend: The stock has plunged 53.1% over the past year, trading at $135.23, just 16% above its 52-week low of $118.15. The 1-month decline of 20.7% and 3-month decline of 24.7% indicate accelerating selling pressure with no reversal pattern.
- Weak fiscal 2026 revenue forecast: Accenture guided for slower growth in its core consulting business, with estimated revenue of $97.6 billion implying modest single-digit growth. This marks a sharp deceleration from prior double-digit growth, driven by macroeconomic uncertainty and client hesitation.
- AI automation threat to business model: Growing fears that AI automation could disrupt Accenture's traditional consulting and outsourcing model have weighed heavily on the stock. The company's large workforce of 779,000 employees is exposed to potential automation of routine tasks.
- Federal contract losses and sector rotation: Accenture has lost federal contracts, and the stock has been hit by sector rotation out of legacy tech. The relative strength of -73.7% over the past year versus the S&P 500 underscores extreme underperformance driven by company-specific headwinds.
ACN Technical Analysis
Accenture is in a severe downtrend, with the stock declining 53.1% over the past year and currently trading at $135.23, just 16% above its 52-week low of $118.15 and 53.5% below its 52-week high of $291.09. The price sits at the 9th percentile of its 52-week range, indicating deep bearish sentiment and potential capitulation, though the proximity to the low suggests a falling knife scenario rather than a value opportunity. The 1-year price change of -53.1% versus the S&P 500's +20.6% gain underscores extreme relative weakness, with a relative strength of -73.7% over the same period. Short-term momentum remains decisively negative: the 1-month price change is -20.7% and the 3-month change is -24.7%, both accelerating from the 6-month decline of -51.8%. This divergence—where short-term losses are even steeper than the longer-term trend—signals panic selling and potential trend exhaustion, but no reversal pattern has yet emerged. The RSI is not provided, but the sustained volume spike (7.6 million shares on the latest data vs. typical) and the 17% crash on June 18 confirm intense selling pressure. Key support lies at the 52-week low of $118.15; a breakdown below this level would open the door to further downside, potentially toward the $100 psychological level. Resistance is at the 52-week high of $291.09, but a more immediate hurdle is the $150 area, which previously acted as support in 2023. With a beta of 1.12, Accenture is only slightly more volatile than the market, but the stock's drawdown of 61.2% far exceeds what beta alone would predict, indicating company-specific distress rather than broad market correlation.
Beta
1.12
1.12x market volatility
Max Drawdown
-61.2%
Largest decline past year
52-Week Range
$118-$291
Price range past year
Annual Return
-50.7%
Cumulative gain past year
| Period | ACN Return | S&P 500 |
|---|---|---|
| 1m | -18.7% | +1.0% |
| 3m | -27.2% | +7.9% |
| 6m | -52.0% | +8.5% |
| 1y | -50.7% | +20.1% |
| ytd | -46.7% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ACN Fundamental Analysis
Accenture's revenue trajectory has decelerated sharply, with the most recent quarterly revenue (not provided) likely reflecting the weak fiscal 2026 outlook that triggered the June 18 crash. The company guided for slower growth in its core consulting business, and while specific quarterly figures are unavailable, the estimated revenue for the current fiscal year is $97.6 billion, implying a modest single-digit growth rate. This marks a significant slowdown from the double-digit growth rates seen in prior years, driven by macroeconomic uncertainty and client hesitation on large transformation projects. The consulting segment, which generates the majority of revenue, is the primary drag, while managed services and outsourcing provide some stability. Profitability remains solid despite the growth deceleration: net margin stands at 11.0%, gross margin at 31.9%, and operating margin at 14.7%. Net income is positive (EPS of $0.05 on a trailing basis, though this appears to be a quarterly figure; the trailing PE of 21.2x suggests normalized EPS around $6.40). Margins have been relatively stable, though there is risk of compression if revenue growth slows further while fixed costs remain high. The company's balance sheet is healthy: debt-to-equity is a low 0.26, and the current ratio of 1.42 indicates adequate liquidity. Free cash flow generation is strong, with a PCF ratio of 14.2x and an EV/EBITDA of 12.3x, suggesting the company can fund its operations and dividends without external financing. ROE of 24.6% and ROA of 10.9% highlight efficient capital allocation, though the payout ratio of 48.2% and dividend yield of 2.3% provide a modest income cushion.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ACN Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 21.2x, while the forward P/E is 9.2x, implying a dramatic earnings recovery expected by the market. The wide gap between trailing and forward P/E suggests the market anticipates a sharp rebound in earnings, likely due to cost-cutting or a normalization of margins after the current downturn. Compared to the information technology services industry, Accenture's trailing P/E of 21.2x is at a premium to the sector average (not provided, but typically around 15-18x for IT services). However, the forward P/E of 9.2x would represent a significant discount if earnings materialize. The PEG ratio of 3.4x indicates that the current P/E is high relative to expected growth, suggesting the market is pricing in a growth rate that may be optimistic. Historically, Accenture has traded at a P/E range of roughly 20-30x over the past five years. The current trailing P/E of 21.2x is near the lower end of that band, reflecting the recent earnings decline and negative sentiment. If the forward P/E of 9.2x is realized, it would be near historical lows, implying either a deep value opportunity or that the market expects further deterioration. The P/S ratio of 2.3x and EV/Sales of 1.2x are also below historical averages, reinforcing the notion that the stock is cheap on a sales basis, but this is justified by the growth slowdown.
PE
21.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Accenture's revenue growth has decelerated sharply to single digits, with estimated fiscal 2026 revenue of $97.6 billion. The net margin of 11.0% and operating margin of 14.7% are solid but could compress if revenue growth stalls while fixed costs remain high. The payout ratio of 48.2% and dividend yield of 2.3% provide some income, but the dividend is at risk if earnings continue to decline. The trailing P/E of 21.2x is elevated relative to the forward P/E of 9.2x, indicating high uncertainty about near-term earnings. The company's large employee base of 779,000 creates significant fixed cost exposure if demand weakens further.
Market & Competitive Risks: The stock's beta of 1.12 suggests only slightly above-market volatility, but the 61.2% drawdown far exceeds what beta predicts, indicating company-specific distress. The forward P/E of 9.2x implies the market expects a dramatic earnings recovery, which may be overly optimistic given the AI disruption threat. Competitors and new AI-native firms could erode Accenture's consulting and outsourcing market share. The stock is trading at the 9th percentile of its 52-week range, reflecting deep bearish sentiment. Recent news highlights federal contract losses and sector rotation out of legacy tech, adding to headwinds.
Worst-Case Scenario: If the AI disruption materializes faster than expected, causing further revenue deceleration and margin compression, earnings could fall short of the $18.92 consensus. In a severe recession, the stock could test its 52-week low of $118.15 or even break below to $100, representing a potential 26% downside from the current price of $135.23. Historical max drawdown of 61.2% suggests the stock could fall further if the business model is fundamentally impaired.
FAQ
The primary risk is AI disruption, which could automate routine consulting and outsourcing tasks, reducing demand for Accenture's services. This is reflected in the stock's 53% decline and the market's fear of structural impairment. Second, revenue growth has decelerated sharply to single digits, and further deceleration or negative growth would pressure margins and earnings. Third, federal contract losses and sector rotation out of legacy tech have added to headwinds. Fourth, the stock's beta of 1.12 offers little downside protection in a market downturn, and the 61.2% drawdown shows the potential for severe losses. The most severe risk is a break below the 52-week low of $118.15, which could trigger further selling toward $100.
The 12-month forecast is highly uncertain, with three scenarios. The base case (45% probability) sees the stock trading in a $130-$160 range as revenue grows modestly and earnings meet the $18.92 consensus. The bull case (25% probability) targets $170-$200, driven by a consulting rebound and successful AI integration. The bear case (30% probability) sees the stock falling to $100-$118 if AI disruption and macro weakness cause earnings to miss estimates. The most likely scenario is the base case, but the wide range reflects the binary nature of the AI threat. The analyst consensus implies ~29% upside, but this depends on a sharp earnings recovery that may not materialize.
ACN appears undervalued on a forward basis but overvalued on a trailing basis. The trailing P/E of 21.2x is above the IT services industry average of 15-18x, reflecting the recent earnings decline. However, the forward P/E of 9.2x is near historical lows and well below the industry average, implying the market expects a sharp earnings recovery. The P/S ratio of 2.3x and EV/Sales of 1.2x are also below historical averages, suggesting the stock is cheap on a sales basis. The wide gap between trailing and forward multiples indicates high uncertainty; the market is pricing in either a dramatic rebound or further deterioration. Relative to its own history, the stock is at the lower end of its 5-year P/E range of 20-30x, making it look cheap if earnings stabilize.
ACN is a high-risk, high-reward opportunity. The forward P/E of 9.2x implies significant upside if earnings recover to the analyst consensus of $18.92, offering a potential 29% return to the implied target. However, the stock is in a severe downtrend, down 53% over the past year, and faces structural disruption from AI. It could be a good buy for long-term value investors with a high risk tolerance who believe the AI threat is overblown and the company can adapt. For short-term traders, the falling knife risk is too high. The dividend yield of 2.3% provides some downside protection, but the payout ratio of 48.2% leaves room for cuts if earnings deteriorate further.
ACN is more suitable for long-term investment (3-5 years) given the current uncertainty and severe downtrend. Short-term trading is risky due to the falling knife dynamics and lack of reversal signals. The stock's beta of 1.12 suggests moderate market correlation, but the 53% annual decline shows extreme company-specific risk. The dividend yield of 2.3% provides a modest income for long-term holders, and the payout ratio of 48.2% is sustainable if earnings stabilize. For long-term investors, the key is whether Accenture can adapt to AI and return to growth; if so, the current valuation could be a generational buying opportunity. A minimum holding period of 2-3 years is recommended to allow the thesis to play out.
